3rd Drug Development Forum
October 1–3, 2018 | Hilton Boston Logan Airport Hotel
Executive-level networking for smarter partnerships and pipeline strategies, more effective development, and improved early research outcomes
FIERCEBIOTECH DRUG DEVELOPMENT FORUM
Where industry leaders set partnership and pipeline strategy
The FierceBiotech Drug Development Forum is an incomparable networking venue where hundreds of biotech C-suite decision makers tackle the greatest problems the industry faces in business development and early R&D.
Our all-new program features unprecedented depth on managing VC relationships, beating ambitious growth plans, developing your immuno-oncology business model, adapting to new regulatory and pricing realities, and maintaining competitive advantage after the next market downturn.
2018 Featured Speakers
2018 KEYNOTE SPEAKERS
KEYNOTE: Pursue Breakthrough Approvals in Multiple Global Markets
TUESDAY, OCTOBER 2, 2018
MODERATOR: Eric Palmer, Editor, FIERCEMARKETS
Ramzi Dagher, Vice President, Worldwide Safety and Regulatory; Regulatory Head, Europe and International, PFIZER
Martine Zimmerman, Senior Vice President, Global Regulatory Affairs, ALEXION PHARMACEUTICALS
Roy Baynes, CMO, Senior Vice President, Head of Clinical Development, MERCK
Maria Fardis, CEO, IOVANCE